ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,326, issued on March 25, was assigned to THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, N.Y.) and The Regents of the University of California (Oakland, Calif.).

"TCO conjugates and methods for delivery of therapeutic agents" was invented by Jose Manuel Mejia Oneto (Oakland, Calif.) and Maksim Royzen (Albany, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible solid support in the patient being linked to a first binding agent, and administering a second binding agent to...